Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0217 |
Primary information | |
---|---|
B3PDB ID | b3pdb_0217 |
Peptide Name | NA |
PEPTIDE SEQUENCE (1-letter) | RGD |
PEPTIDE SEQUENCE (3-letter) | ArgGlyAsp |
N-terminal modification | NA |
C-terminal modification | NA |
Chemical modification | NA |
Peptide Length | 3 |
Conformation | Cyclic |
Peptide Nature | Cationic |
Source/Origin of peptide | Chemically synthesized |
SMILES | NA |
Cell Line | BCEC cell line |
In vitro CONCENTRATION | 0.3 microgram of peptide per ml |
In vitro METHOD | Competition assay |
In vitro RESULT | Nearly 5% diffuse into acceptor chamber after 2 hours |
ANIMAL MODEL | NA |
In vivo CONCENTRATION | NA |
In vivo MODE OF DELIVERY | NA |
In vivo METHOD | NA |
In vivo RESULT | NA |
ACTION | NA |
TRANSPORT TYPE | NA |
SUBCELLULAR LOCALISATION | NA |
COMBINATION | peptide combined with paclitaxel and Doxorubicin |
PHYSICAL CONDITION | Brain glioma therapy |
RESPONSE | NA |
RESULT | NA |
LABEL | NA |
PMID | 27143884 |